![Win J. Travassos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Win J. Travassos
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Digestive Health Specialists PC
3
| Private Company | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Win J. Travassos
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Windgap Medical, Inc.
![]() Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Pharmaceuticals: Major | Director/Board Member | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
The University of Texas at Arlington | College/University | Graduate Degree | |
FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member | |
TWI PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact | |
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Director/Board Member | |
Regenacy Pharmaceuticals LLC
![]() Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Point Robotics Medtech, Inc.
![]() Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Point Robotics Medtech, Inc. is a private company based in Taiwan that specializes in minimally invasive surgical technologies. In May 2020, the Taiwanese company completed its series-A fundraising from government funds, Taiwania Capital, and Translink Capital. Point Robotics Medtech will continue to focus on the development and regulatory approvals of next-generation products to maintain its leading position in the high-end surgical robotics market. Founded in 2016, the company has two major product lines\: the "Kinguide Robotic-Assisted Surgical System" and the "Kinguide Agile Hybrid Navigation System." | Wholesale Distributors | Director/Board Member | |
Neurovive Pharmaceutical Asia, Inc. | Chief Executive Officer | ||
Jones Graduate School of Business | College/University | Masters Business Admin | |
VIRACTA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 11 |
Taiwan | 4 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Distribution Services | 2 |
Operativ
Director/Board Member | 12 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Graduate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Huang | 15 |
Geetanjali A. Akerkar | 1 |
James H. Reichheld | 1 |
- Börse
- Insiders
- Win J. Travassos
- Unternehmensverbindungen